Global drugmakers warn about suspension of clinical trials in Russia

The Russian Association of Clinical Research Organizations in Russia, a trade association which unites leading Russian drugmakers and foreign pharmaceutical companies operating in the local market, has warned the national government about the possible suspension of clinical trials and examination of drugs in Russia, which is a result of the suspension of regular and charter flights in the country due to the coronavirus pandemic, starting from March, 27, according to recent statements by representatives of the Association.

According to Svetlana Zavidova, executive director of the association, there is a need to clarify whether flight restrictions, introduced by the government, also apply to air freight, which ensures 70% of drug deliveries for clinical trials in Russia.

As Ms Zavidova has also added global drugmakers operating in Russia conducting clinical trials of their drugs within the country usually use air freight for the imports of drugs into Russia and exports of biological samples out of the country. According to the association, the annual number of participants of these clinical trials in Russia is estimated at 50,000 people.